Science & Technology
An accurate, affordable, and transferable assay for minimally invasive detection of esophageal squamous cell carcinoma (ESCC) in Africa and the United States
Department of Health and Human Services — National Institutes of Health
Opportunity #: 2R42CA261376-02A1
Award Ceiling
$885K
Award Floor
$885K
Close Date
Aug 31, 2026
169 days leftTotal Funding
$885K
Expected Awards
1
Posted Date
Sep 20, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-2R42CA261376-02A1
Description
STTR Phase Phase II award: "An accurate, affordable, and transferable assay for minimally invasive detection of esophageal squamous cell carcinoma (ESCC) in Africa and the United States" awarded to CAPSULOMICS INC in WILMINGTON, Delaware. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $885,000. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.